Donastar Becomes Exclusive Master Distributor of Nephros Commercial Water Filters
for Food & Beverage and Hospitality Markets
“Since early 2022, when our two companies entered an alliance with Tractor Beverage to supply commercial water filters to a national and widely recognized
“Nephros is perennially focused on providing a comprehensive collection of water filtration solutions in support of improving water quality. Our work with Donastar allows us to capitalize on our commercial capabilities, and has already yielded significant customer momentum and growth potential,” said
About Nephros
Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency solutions for water management.
For more information about Nephros, please visit nephros.com.
About
Donastar is a primary provider of foodservice and beverage equipment service as well as water filtration systems. With over 500 service partners and thousands of trained technicians, we support operators all throughout
For more information, please visit donastar.com.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are provided under the protection of the safe harbor for forward-looking statements provided by such law. These forward-looking statements are subject to various risks and uncertainties. Such statements include statements regarding Nephros’ expectations concerning the future success of its distribution arrangement with Donastar and its commercial water filtration business generally, future revenue from Nephros’ commercial filtration business and its ability to obtain additional contracts to supply QSR chains and other national end customers, and other statements that are not historical facts, including statements that may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, Nephros’ ability to obtain market acceptance of its products, the availability of capital when needed, dependence on third-party manufacturers and researchers, regulatory reforms. These and other risks and uncertainties are detailed in Nephros’ most recent Annual Report on Form 10-K and such other reports filed with the
Investor Relations Contacts:
(646) 823-8656
ksmith@pcgadvisory.com
(201) 343-5202 x120
andy.astor@nephros.com
Source:
2023 GlobeNewswire, Inc., source